Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
XPEV compared with ZLAB: revenue, margins and what each company keeps, and the suppliers and customers both name
XPEV
Xpeng Inc.
Change
Mkt cap
Revenue
Revenue
ZLAB
Zai Lab Ltd
Change
Mkt cap
Revenue
Revenue
vs
Compare
XPEV
Xpeng Inc.
vs
ZLAB
Zai Lab Ltd
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
XPEV: latest quarter not drawable. ZLAB: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
XPEV, solid
ZLAB, dashed
XPEV
Xpeng Inc.
Change
9.03
▼
−1.69%
· post 9.00
Mkt cap
$8.6B
Revenue
—
Revenue
—
ZLAB
Zai Lab Ltd
Change
22.09
▼
−1.21%
· post 22.10
Closed
Oct 30 '26
Mkt cap
$2.5B
Revenue
$106M
Q2 FY26
Revenue
$460M
FY25
vs
Compare
Closed
Oct 30 '26
XPEV
Xpeng Inc.
vs
ZLAB
Zai Lab Ltd
9.03
▼
−1.69%
post 9.00
Price
22.09
▼
−1.21%
post 22.10
$8.6B
Mkt cap
$2.5B
—
Revenue
$106M
Q2 FY26
—
Revenue
$460M
FY25
Change
Change
XPEV
9.03
▼
−1.69%
vs
ZLAB
22.09
▼
−1.21%
Closed
Oct 30 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only XPEV
2
ADNT
Adient
supplier
—
DiDi
unlisted
supplier
Shared
0
No shared counterparties.
Only ZLAB
9
PFE
Pfizer
supplier
VRTX
Vertex Pharmaceuticals
supplier
BMY
Bristol-Myers Squibb
supplier
INVA
Innoviva
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
5 more · ZLAB chain
›